Integrated BioPharma, Inc. (INBP)

Integrated BioPharma Revenue

In the fiscal year ending June 30, 2026, Integrated BioPharma had annual revenue of $43.87M, down -19.28%. Integrated BioPharma had revenue of $9.80M in the quarter ending June 30, 2026, a decrease of -30.89%. That makes Integrated BioPharma the 28,891st largest company in the world by revenue and 3,872nd in the United States.

• Revenue: 43.87M
• Revenue Growth: -19.28%
• P/S Ratio: 0.12
• Revenue / Employee: 327.40K
• Employees: 134
• Market Cap: 5.12M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Contract Manufacturing 42.39M 96.6%
• Other Business Lines 1.48M 3.4%

By Geography

Chart

• United States 35.23M 80.3%
• International 8.64M 19.7%

Fiscal year ended Jun 30, 2026 See the full Integrated BioPharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	43.87M	-10.48M	-19.28%
Jun 30, 2025	54.35M	4.04M	8.02%
Jun 30, 2024	50.32M	-355.00K	-0.70%
Jun 30, 2023	50.67M	-5.57M	-9.91%
Jun 30, 2022	56.25M	-7.31M	-11.51%

Data Source: S&P Global Market Intelligence Last updated: Sep 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error